Finance

Lists
Why is 1541 up 2,58%?
Dive Deeper
1541:HKG
ImmuneOnco Biopharmaceuticals(Shngh) Inc
2,98 HK$
+2,58%
(+0,075) 1D
16 հոկ, 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1541...
Open
2,98 HK$
High
3,07 HK$
Low
2,92 HK$
Mkt. cap
1,28 մլրդ
Avg. vol.
385,40 հզր
Volume
273,40 հզր
52-wk high
11,90 HK$
52-wk low
2,80 HK$
EPS
-0,63 HK$
No. of employees
197
Open
2,98 HK$
High
3,07 HK$
Low
2,92 HK$
Mkt. cap
1,28 մլրդ
Avg. vol.
385,40 հզր
Volume
273,40 հզր
52-wk high
11,90 HK$
52-wk low
2,80 HK$
EPS
-0,63 HK$
No. of employees
197
News stories
From web sources and news partners
About ImmuneOnco Biopharmaceuticals(Shngh) Inc
CEO-
Employees197
Founded2015
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
55,14 մլն
55,14 մլն
18,62 մլն
18,62 մլն
Cost of goods sold
555,00 հզր
555,00 հզր
-
-
Cost of revenue
555,00 հզր
555,00 հզր
-
-
Research and development expenses
77,12 մլն
77,12 մլն
77,39 մլն
77,39 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13,34 մլն
13,34 մլն
11,60 մլն
11,60 մլն
Operating expense
90,46 մլն
90,46 մլն
88,99 մլն
88,99 մլն
Total operating expenses
91,01 մլն
91,01 մլն
88,99 մլն
88,99 մլն
Operating income
-35,87 մլն
-35,87 մլն
-70,36 մլն
-70,36 մլն
Other non operating income
4,90 մլն
4,90 մլն
-6,50 հզր
-6,50 հզր
EBT including unusual items
-33,27 մլն
-33,27 մլն
-82,74 մլն
-82,74 մլն
EBT excluding unusual items
-33,47 մլն
-33,47 մլն
-77,67 մլն
-77,67 մլն
Income tax expense
14,50 հզր
14,50 հզր
11,50 հզր
11,50 հզր
Effective tax rate
-0,04%
-0,04%
-0,01%
-0,01%
Other operating expenses
-
-
-
-
Net income
-33,00 մլն
-33,00 մլն
-82,09 մլն
-82,09 մլն
Net profit margin
-59,84%
-59,84%
-440,81%
-440,81%
Earnings per share
-
-
-
-
Interest and investment income
1,57 մլն
1,57 մլն
2,28 մլն
2,28 մլն
Interest expense
-1,43 մլն
-1,43 մլն
-2,12 մլն
-2,12 մլն
Net interest expenses
136,00 հզր
136,00 հզր
165,50 հզր
165,50 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-33,84 մլն
-33,84 մլն
-68,41 մլն
-68,41 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps